Evidence map›Paper›PMID 32510933›Full record

ArticleBiochemistry2020

Human γS-Crystallin-Copper Binding Helps Buffer against Aggregation Caused by Oxidative Damage.

Kyle W Roskamp, Sana Azim, Günther Kassier, Brenna Norton-Baker, Marc A Sprague-Piercy, R J Dwyane Miller, Rachel W Martin

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Manipulating polydispersity of lens β-crystallins using divalent cations demonstrates evidence of calcium regulation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Kyle W RoskampDepartment of Chemistry, University of California, Irvine, California 92697-2025, United States.
Sana AzimMax Planck Institute for the Structure and Dynamics of Matter, Center for Free Electron Laser Science, Luruper Chaussee 149, Hamburg 22761, Germany.
Günther KassierMax Planck Institute for the Structure and Dynamics of Matter, Center for Free Electron Laser Science, Luruper Chaussee 149, Hamburg 22761, Germany.
Brenna Norton-BakerDepartment of Chemistry, University of California, Irvine, California 92697-2025, United States.
Marc A Sprague-PiercyDepartment of Molecular Biology and Biochemistry, University of California, Irvine, California 92697-3900, United States.
R J Dwyane MillerMax Planck Institute for the Structure and Dynamics of Matter, Center for Free Electron Laser Science, Luruper Chaussee 149, Hamburg 22761, Germany.ORCID 0000-0003-0884-0541
Rachel W MartinDepartment of Chemistry, University of California, Irvine, California 92697-2025, United States.ORCID 0000-0001-9996-7411
Universität Hamburg · DEUniversity of California, Irvine · US

Funding

Solid-state NMR methods for investigating native and aggregated eye lens proteinsR01EY021514 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI MARTIN, RACHEL WAGNER · 2011 to 2022
$2.8M
Toward Molecular-Scale Models of Congenital and Age-Related Cataract: a Concerted Computational and Experimental ApproachR01EY025328 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI TOBIAS, DOUGLAS J · 2016 to 2018
$977k
Howard Hughes Medical InstituteNEI NIH HHS R01 EY021514NEI NIH HHS R01 EY025328
6 · The paper itself

Abstract

Divalent metal cations can play a role in protein aggregation diseases, including cataract. Here we compare the aggregation of human γS-crystallin, a key structural protein of the eye lens, via mutagenesis, ultraviolet light damage, and the addition of metal ions. All three aggregation pathways result in globular, amorphous-looking structures that do not elongate into fibers. We also investigate the molecular mechanism underlying copper(II)-induced aggregation. This work was motivated by the observation that zinc(II)-induced aggregation of γS-crystallin is driven by intermolecular bridging of solvent-accessible cysteine residues, while in contrast, copper(II)-induced aggregation of this protein is exacerbated by the removal of solvent-accessible cysteines via mutation. Here we find that copper(II)-induced aggregation results from a complex mechanism involving multiple interactions with the protein. The initial protein-metal interactions result in the reduction of Cu(II) to Cu(I) with concomitant oxidation of γS-crystallin. In addition to the intermolecular disulfides that represent a starting point for aggregation, intramolecular disulfides also occur in the cysteine loop, a region of the N-terminal domain that was previously found to mediate the early stages of cataract formation. This previously unobserved ability of γS-crystallin to transfer disulfides intramolecularly suggests that it may serve as an oxidation sink for the lens after glutathione levels have become depleted during aging. γS-Crystallin thus serves as the last line of defense against oxidation in the eye lens, a result that underscores the chemical functionality of this protein, which is generally considered to play a purely structural role.

Indexed as

CopperCysteineDisulfidesgamma-CrystallinsHumansMutationOxidation-ReductionProtein BindingProtein MultimerizationUltraviolet RaysCopperCRYGS protein, humanCysteineDisulfidesgamma-Crystallins

Identifiers

PMID32510933
PMCPMC7732359
OpenAlexW3032943766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.